Price data is not available
Mereo BioPharma Group (MREO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | FY '23 | FY '22 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||||
| Estimate | $-0.01 | $0.02 | $-0.01 | $-0.01 | — | — |
| Actual | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.04 | $-0.07 |
| Surprise | 0.00% | -150.0% | 0.00% | 0.00% | — | — |
| Revenue | ||||||
| Estimate | $863830 | $10.5M | $5.3M | $16.2M | — | — |
| Actual | $0 | $0 | $0 | $0 | $10.0M | $50.2M |
| Surprise | -100.0% | -100.0% | -100.0% | -100.0% | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Revenue | ||||
| Consensus | — | $12330 | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.01 | $-0.01 | 0.00 % |
| Q1 | May 12, 2026 | $-0.01 | $0.02 | -150.0 % |
| Q4 | Mar 19, 2026 | $-0.01 | $-0.01 | 0.00 % |
| Q3 | Nov 10, 2025 | $-0.01 | $-0.01 | 0.00 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $0 | $863.83K | -100.0 % |
| Q1 | May 12, 2026 | $0 | $10.49M | -100.0 % |
| Q4 | Mar 19, 2026 | $0 | $5.30M | -100.0 % |
| Q3 | Nov 10, 2025 | $0 | $16.22M | -100.0 % |